Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients
1 other identifier
interventional
80
1 country
1
Brief Summary
Quality of life is recommended as one of essential parameters to evaluate treatment effect and clinical outcome in patients with Crohn's disease (CD). Recent studies reported that several disease-unrelated variables may affect quality of life in CD patients. This study is dedicated to investigate the influence of various personality traits on quality of life, and whether or not they should be taken into account when evaluating clinical outcomes in patients with CD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 19, 2013
CompletedFirst Posted
Study publicly available on registry
June 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJune 27, 2013
June 1, 2013
1.8 years
June 19, 2013
June 24, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IBDQ
Inflammatory Bowel Disease Questionnaires (IBDQ) is the most widely used and validated disease-specific instrument, which contains 32 items and assesses four aspects (subscales) of quality of life: emotional function (12 items), social function (5 items), bowel function (10 items) and systemic symptom (5 items).
one week
Secondary Outcomes (3)
Eysenck Personality Inventory (EPI)
one week
Hospital Anxiety and Depression Scale (HADS)
one week
Buss Perry Aggregation (BPA) questionnaire
one week
Study Arms (2)
Active CD
EXPERIMENTALPatients whose CDAI score \>150 points would be enrolled in this group.
Quiescent CD
ACTIVE COMPARATORPatients whose CDAI score ≤150 points would be enrolled in this group.
Interventions
Patients are required to fill out several personality traits questionnaires. The following personality traits scores would be collected: IBDQ, IBDQ-Emotional function score, IBDQ-Social function score, IBDQ-Bowel function score, IBDQ-Systemic symptom score, Neuroticism score, Lie (social conformity/desirability) score, Hospital anxiety score, Hospital depression score, Buss-Perry score, PA (physical aggression) score, VA (verbal aggression) score, A (anger) score, H (hostility) score.
Eligibility Criteria
You may qualify if:
- years old
- a definite diagnosis of CD
You may not qualify if:
- current or previous mental disorders
- receiving or once received psychotherapy
- presence of major medical conditions (such as necessity of an operation)
- chronic disease history other than inflammatory bowel disease
- unwilling to participate in or cannot accomplish current study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery, Jinling Hospital
Nanjing, Jiangsu, 210002, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice president of department of surgery, Jinling Hospital
Study Record Dates
First Submitted
June 19, 2013
First Posted
June 27, 2013
Study Start
March 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
June 27, 2013
Record last verified: 2013-06